MedPath

Comparing Oral Tofacitinib and Topical Triamcinolone Acetonide for Oral Lichen Planus: A Randomized Trial

Phase 2
Conditions
Health Condition 1: L438- Other lichen planus
Registration Number
CTRI/2024/07/070729
Lead Sponsor
ostgraduate Institute of Medical Education and Research Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Clinician-confirmed diagnosis of symptomatic oral lichen planus having exclusive oral involvement or predominant oral involvement with few cutaneous lesions

2. Patients aged between 18-60 years of age

3. Patients providing informed consent and are willing to follow up monthly for at least 6 months

Exclusion Criteria

1. Pregnant and lactating women

2. Women with childbearing potential who are unwilling to follow reliable methods of contraception

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath